James Fletcher

10.3k total citations · 3 hit papers
73 papers, 4.4k citations indexed

About

James Fletcher is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, James Fletcher has authored 73 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Radiology, Nuclear Medicine and Imaging, 24 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in James Fletcher's work include Medical Imaging Techniques and Applications (16 papers), Radiopharmaceutical Chemistry and Applications (11 papers) and Medical Imaging and Pathology Studies (7 papers). James Fletcher is often cited by papers focused on Medical Imaging Techniques and Applications (16 papers), Radiopharmaceutical Chemistry and Applications (11 papers) and Medical Imaging and Pathology Studies (7 papers). James Fletcher collaborates with scholars based in United States, Belgium and United Kingdom. James Fletcher's co-authors include Paul E. Kinahan, Robert Timmerman, Ronald C. McGarry, David A. Culver, David J. Bean, Mary M. Boucherle, Constantin T. Yiannoutsos, Mark D. Williams, Lech Papież and J. DeLuca and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

James Fletcher

72 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer

2006 1.1k citations James Fletcher et al. profile →
Recommendations on the Use of ¹⁸F-FDG PET in Oncology

2008 790 citations James Fletcher, Benjamin Djulbegović et al. Journal of Nuclear Medicine profile →
Positron Emission Tomography-Computed Tomography Standardized Uptake Values in Clinical Practice and Assessing Response to Therapy

2010 425 citations Paul E. Kinahan, James Fletcher Seminars in Ultrasound CT and MRI profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Fletcher United States	21	2.2k	1.8k	1.0k	513	445	73	4.4k
Ingemar Näslund Sweden	28	1.3k 0.6×	933 0.5×	1.4k 1.3×	337 0.7×	438 1.0×	71	3.1k
Michael J. Seider United States	22	2.0k 0.9×	433 0.2×	1.1k 1.1×	269 0.5×	366 0.8×	53	3.0k
Michael Andersson Denmark	19	463 0.2×	408 0.2×	493 0.5×	1.0k 2.0×	865 1.9×	29	3.5k
Stephen Davis United States	24	801 0.4×	650 0.4×	988 1.0×	348 0.7×	134 0.3×	93	2.4k
Sharon E. Clarke United Kingdom	23	427 0.2×	816 0.5×	62 0.1×	164 0.3×	455 1.0×	85	2.1k
Joshua Jones United States	22	326 0.1×	183 0.1×	234 0.2×	424 0.8×	700 1.6×	108	1.9k
Andrew K. Lee United States	43	4.2k 1.9×	1.2k 0.7×	2.8k 2.7×	756 1.5×	937 2.1×	125	7.0k
Takeshi Matsunaga Japan	33	1.6k 0.7×	768 0.4×	33 0.0×	287 0.6×	254 0.6×	228	3.7k
David Kozono United States	36	1.5k 0.7×	494 0.3×	241 0.2×	1.0k 2.0×	443 1.0×	135	5.3k
Alex G. Little United States	46	2.9k 1.3×	418 0.2×	46 0.0×	747 1.5×	3.3k 7.4×	161	6.7k

Countries citing papers authored by James Fletcher

Since Specialization

Citations

This map shows the geographic impact of James Fletcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Fletcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Fletcher more than expected).

Fields of papers citing papers by James Fletcher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Fletcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Fletcher. The network helps show where James Fletcher may publish in the future.

Co-authorship network of co-authors of James Fletcher

This figure shows the co-authorship network connecting the top 25 collaborators of James Fletcher. A scholar is included among the top collaborators of James Fletcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Fletcher. James Fletcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hutchins, Gary D., Clinton D. Bahler, Mark Tann, et al.. (2019). [68Ga]Ga-P16-093 as a PSMA-Targeted PET Radiopharmaceutical for Detection of Cancer: Initial Evaluation and Comparison with [68Ga]Ga-PSMA-11 in Prostate Cancer Patients Presenting with Biochemical Recurrence. Molecular Imaging and Biology. 22(3). 752–763. 27 indexed citations

Risacher, Shannon L., Eileen F. Tallman, John D. West, et al.. (2017). Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography. PMC. 1 indexed citations

Green, Mark A., James Fletcher, Carla J. Mathias, et al.. (2016). Estimation of radiation dosimetry for 68Ga-HBED-CC (PSMA-11) in patients with suspected recurrence of prostate cancer. Nuclear Medicine and Biology. 46. 32–35. 20 indexed citations

Brown, Shannon, et al.. (2016). Bevacizumab-Induced Pityriasis Rubra Pilaris-Like Eruption. Baylor University Medical Center Proceedings. 29(3). 335–336. 4 indexed citations

Fletcher, James, Benjamin Djulbegović, Heloisa P. Soares, et al.. (2014). Recommendations on the Use of 18F-FDG PET in Oncology.

Lacy, Jeffrey L., et al.. (2014). Performance of a 62Zn/62Cu microgenerator in kit-based synthesis and delivery of [62Cu]Cu–ETS for PET perfusion imaging. Applied Radiation and Isotopes. 91. 38–43. 7 indexed citations

Fletcher, James, Theodore F. Logan, Carla J. Mathias, et al.. (2014). Whole-Body PET/CT Evaluation of Tumor Perfusion Using Generator-Based ⁶²Cu-Ethylglyoxal Bis(Thiosemicarbazonato)Copper(II): Validation by Direct Comparison to ¹⁵O-Water in Metastatic Renal Cell Carcinoma. Journal of Nuclear Medicine. 56(1). 56–62. 12 indexed citations

Lea, William, et al.. (2014). Microsphere Localization and Dose Quantification Using Positron Emission Tomography/CT following Hepatic Intraarterial Radioembolization with Yttrium-90 in Patients with Advanced Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. 25(10). 1595–1603. 22 indexed citations

Lea, William, et al.. (2014). The Impact of Image Reconstruction Bias on PET/CT ⁹⁰Y Dosimetry After Radioembolization. Journal of Nuclear Medicine. 55(9). 1452–1458. 28 indexed citations

10.

Kinahan, Paul E. & James Fletcher. (2010). Positron Emission Tomography-Computed Tomography Standardized Uptake Values in Clinical Practice and Assessing Response to Therapy. Seminars in Ultrasound CT and MRI. 31(6). 496–505. 425 indexed citations breakdown →

11.

Sandrasegaran, Kumaresan, et al.. (2008). Can FDG-PET be used to predict growth of stage I lung cancer?. Clinical Radiology. 63(8). 856–863. 17 indexed citations

12.

Beard, Brian C., David Dickerson, James Fletcher, et al.. (2007). Comparison of HIV-derived Lentiviral and MLV-based Gammaretroviral Vector Integration Sites in Primate Repopulating Cells. Molecular Therapy. 15(7). 1356–1365. 90 indexed citations

13.

Gould, Michael K., James Fletcher, Mark D. Iannettoni, et al.. (2007). Evaluation of Patients With Pulmonary Nodules: When Is It Lung Cancer?. CHEST Journal. 132(3). 108S–130S. 373 indexed citations

14.

Conway, Charles R., Yvette I. Sheline, John T. Chibnall, et al.. (2006). Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Research Neuroimaging. 146(2). 179–184. 104 indexed citations

15.

Lowe, Val J., et al.. (1999). Primary and Recurrent Early Stage Laryngeal Cancer: Preliminary Results of 2-[Fluorine 18]fluoro-2-deoxy-d-glucose PET Imaging. Radiology. 212(3). 799–802. 20 indexed citations

16.

Fletcher, James. (1998). Design of Prospective Clinical Trials for Assessment of PET. PubMed. 1(3). 201–211. 2 indexed citations

17.

Fletcher, James, Steven H. Woolf, & Henry D. Royal. (1994). Consensus development for producing diagnostic procedure guidelines: SPECT brain perfusion imaging with exametazime.. PubMed. 35(12). 2003–10. 14 indexed citations

18.

Fletcher, James, et al.. (1986). Numerical T1 computation from NMR intensity ratios. Magnetic Resonance Imaging. 4(4). 311–319. 1 indexed citations

19.

Fletcher, James, et al.. (1980). Sequential thallium-201 myocardial scintigraphy after acute infarction in man. Radiology. 2 indexed citations

20.

Fletcher, James. (1963). Hand, Foot, and Mouth Disease. BMJ. 2(5371). 1532.4–1532. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact